Authority-required PBS listings for Aboriginal and Torres Strait Islander peoples (as at 1 July 2009)

Since August 2006 a number of medicines have been listed on the Pharmaceutical Benefits Scheme (PBS) specifically for people who identify as Aboriginal or Torres Strait Islander. The Pharmaceutical Benefits Advisory Committee recommended these authority-required listings to improve the capacity of the PBS to meet the particular healthcare needs of these people. Most are streamlined authority listings.
Box 1 lists the medicines currently subsidised on the PBS for treating common conditions in Aboriginal and Torres Strait Islander peoples.
To keep up to date with future listings, go to the health professionals' site at, click on 'PBS publications' and scroll to the 'PBS listings for Aboriginal and Torres Strait Islander people' fact sheet.

Box 1 Authority-required PBS listings* for Aboriginal and Torres Strait Islander peoples (as at 1 July 2009)

Treating condition

Subsidised medicine

Fungal or yeast infection

Bifonazole cream, 1%
Clotrimazole cream, 1%
Ketoconazole cream, 1%; shampoo, 2%
Miconazole nitrate cream, powder, lotion, 2%
Miconazole tincture, 2%
Nystatin cream, 100 000 units per gram
Terbinafine hydrochloride cream, 1%

Thiamine deficiency (prophylaxis)

Thiamine hydrochloride tablet, 100 mg

Whipworm infestation

Albendazole tablet, 200 mg

Chronic suppurative otitis media
(age ≥ 1 month)

Ciprofloxacin ear drops, 0.3%

Dermatophyte infection when topical treatment has failed

Terbinafine hydrochloride tablet, 250 mg

Nicotine dependence as the sole PBS-subsidised therapy

Nicotine transdermal patch, releasing approximately 15 mg per 16 hours

Nasal colonisation with Staphylococcus aureus

Mupirocin nasal ointment, 2%

* Authority-required listings are streamlined except for ciprofloxacin ear drops and terbinafine hydrochloride tablets